Neurocrine Biosciences | NBIX - Stock





Stock Veränderung Datum
AbbVie USD 5.05B 98M 2026-03
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
ALKERMES USD 336.7M 140.08M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amgen USD 6.19B 39M 2026-03
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Exelixis USD 26.6M 4.92M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
Halozyme Therapeutics USD 155.47M 21.01M 2026-03
Incyte USD 115.62M 14.56M 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Pfizer USD 10.67B 13M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Repligen USD 179.26M 8.8M 2026-03
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Sarepta Therapeutics USD 1B 86.37M 2026-03
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03